Top section
Top section
High yields and tight senior/sub spread fuel enthusiasm for issuance among investors and issuers
◆ Pair help market to end week on a high note ◆ GSK offers pick-up over peer AstraZeneca ◆ Glencore finds demand at eight years
◆ French borrower takes €1.15bn across two tranches ◆ Balance struck between size and price to keep investors onside ◆ Small concession offered
Data
More articles
More articles
More articles
-
◆ Capped size helped lead to strong outcome ◆ Low single digit concessions needed for both tranches ◆ Floating rate tranche taps into money market demand -
Former MDB sustainable finance expert joins as HSBC rebuilds sustainability leadership
-
Deal has two tranches, company last came to market in 2024
-
Oilfield services company readies four-tranche Reverse Yankee
-
Elevated NIPs not to be uniform, with some sectors set to pay more than others
-
Conservative tenors likely to be in demand when issuance resumes
Sub-sections
